Revance Therapeutics, Inc. - COM (RVNC)

Q2 2015 13F Holders as of 6/30/2015

Type / Class
Equity / COM
Number of holders
86
Total Shares
17.4M
Shares change
-52.6K
Total reported value, excl. options
$556M
Value change
+$16M
Put/Call ratio
0
Number of buys
64
Number of sells
-26
Price
$31.98
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.